Coated Endotracheal Tube Market (Intubation: Orotracheal Intubation and Nasotracheal Intubation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Description

List of Tables

The report provides revenue of the global coated endotracheal tube market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global coated endotracheal tube market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the coated endotracheal tube market.

The report delves into the competitive landscape of the global coated endotracheal tube market. Key players operating in the global coated endotracheal tube market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global coated endotracheal tube market profiled in this report.

Product Code: TMRGL49899

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Coated Endotracheal Tube Market

4. Market Overview

4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Coated Endotracheal Tube Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Technological Advancements
5.2. Key Industry Events (partnership, merger & acquisition, etc.)
5.3. COVID-19 Impact Analysis
5.4. Insights on Healthcare Associated Infection (HAI)

6. Global Coated Endotracheal Tube Market Analysis and Forecast, by Intubation

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Intubation, 2017-2031
- 6.3.1. Orotracheal Intubation
- 6.3.2. Nasotracheal Intubation
6.4. Market Attractiveness Analysis, by Intubation

7. Global Coated Endotracheal Tube Market Analysis and Forecast, by Application

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Anesthesia
- 7.3.2. Congenital Respiratory Disorder
- 7.3.3. Ventilator-associated Pneumonia (VAP)
- 7.3.4. Others
7.4. Market Attractiveness Analysis, by Application

8. Global Coated Endotracheal Tube Market Analysis and Forecast, by End-user

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Clinics
- 8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-user

9. Global Coated Endotracheal Tube Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region

10. North America Coated Endotracheal Tube Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Intubation, 2017-2031
- 10.2.1. Orotracheal Intubation
- 10.2.2. Nasotracheal Intubation
10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Anesthesia
- 10.3.2. Congenital Respiratory Disorder
- 10.3.3. Ventilator-associated Pneumonia (VAP)
- 10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Clinics
- 10.4.3. Ambulatory Surgical Centers
10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. Market Attractiveness Analysis
- 10.6.1. By Intubation
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country

11. Europe Coated Endotracheal Tube Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Intubation, 2017-2031
- 11.2.1. Orotracheal Intubation
- 11.2.2. Nasotracheal Intubation
11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Anesthesia
- 11.3.2. Congenital Respiratory Disorder
- 11.3.3. Ventilator-associated Pneumonia (VAP)
- 11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Clinics
- 11.4.3. Ambulatory Surgical Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Intubation
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region

12. Asia Pacific Coated Endotracheal Tube Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Intubation, 2017-2031
- 12.2.1. Orotracheal Intubation
- 12.2.2. Nasotracheal Intubation
12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Anesthesia
- 12.3.2. Congenital Respiratory Disorder
- 12.3.3. Ventilator-associated Pneumonia (VAP)
- 12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Clinics
- 12.4.3. Ambulatory Surgical Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Intubation
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region

13. Latin America Coated Endotracheal Tube Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Intubation, 2017-2031
- 13.2.1. Orotracheal Intubation
- 13.2.2. Nasotracheal Intubation
13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Anesthesia
- 13.3.2. Congenital Respiratory Disorder
- 13.3.3. Ventilator-associated Pneumonia (VAP)
- 13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Clinics
- 13.4.3. Ambulatory Surgical Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Intubation
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Coated Endotracheal Tube Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value & Forecast, by Intubation, 2017-2031
- 14.2.1. Orotracheal Intubation
- 14.2.2. Nasotracheal Intubation
14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Anesthesia
- 14.3.2. Congenital Respiratory Disorder
- 14.3.3. Ventilator-associated Pneumonia (VAP)
- 14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Clinics
- 14.4.3. Ambulatory Surgical Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Intubation
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
- 15.3.1. BD (C. R. Bard)
  - 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.1.2. Financial Overview
  - 15.3.1.3. Product Portfolio
  - 15.3.1.4. SWOT Analysis
  - 15.3.1.5. Strategic Overview
- 15.3.2. Venner Medical
  - 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.2.2. Financial Overview
  - 15.3.2.3. Product Portfolio
  - 15.3.2.4. SWOT Analysis
  - 15.3.2.5. Strategic Overview
- 15.3.3. Sterimed Group
  - 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.3.2. Financial Overview
  - 15.3.3.3. Product Portfolio
  - 15.3.3.4. SWOT Analysis
  - 15.3.3.5. Strategic Overview
- 15.3.4. Bactiguard AB
  - 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.4.2. Financial Overview
  - 15.3.4.3. Product Portfolio
  - 15.3.4.4. SWOT Analysis
  - 15.3.4.5. Strategic Overview
- 15.3.5. N8 Medical, LLC.
  - 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.5.2. Financial Overview
  - 15.3.5.3. Product Portfolio
  - 15.3.5.4. SWOT Analysis
  - 15.3.5.5. Strategic Overview
- 15.3.6. Desco Medical India
  - 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.6.2. Financial Overview
  - 15.3.6.3. Product Portfolio
  - 15.3.6.4. SWOT Analysis
  - 15.3.6.5. Strategic Overview
- 15.3.7. Fuji Systems
  - 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.7.2. Financial Overview
  - 15.3.7.3. Product Portfolio
  - 15.3.7.4. SWOT Analysis
  - 15.3.7.5. Strategic Overview
- 15.3.8. Other prominent players